Skip to content
PIL Logo

MOVICOL Paediatric Plain 6.9 g sachet, powder for oral solution

Last Updated on eMC 15-Feb-2017 View document  | Norgine Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15-Feb-2017 and displayed until Current

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 10-Dec-2015 and displayed until 15-Feb-2017

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 17-Sep-2015 and displayed until 10-Dec-2015

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Correction of spelling/typing errors

Updated on 07-May-2015 and displayed until 17-Sep-2015

Reasons for adding or updating:

  • Change to section 1 - what the product is
  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 2 - driving and using machines
  • Change to section 3 - dose and frequency
  • Change to section 3 - how to take/use
  • Change to section 3 - duration of treatment
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 5 - how to store
  • Change to section 6 - what the product contains
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 05-Nov-2013 and displayed until 07-May-2015

Reasons for adding or updating:

  • Correction of spelling/typing errors

Updated on 12-Jun-2013 and displayed until 05-Nov-2013

Reasons for adding or updating:

  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 6 - date of revision

Updated on 07-Jan-2011 and displayed until 12-Jun-2013

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 09-Dec-2010 and displayed until 07-Jan-2011

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 30-Nov-2010 and displayed until 09-Dec-2010

Reasons for adding or updating:

  • Change to side-effects

Updated on 15-Mar-2010 and displayed until 30-Nov-2010

Reasons for adding or updating:

  • Change to side-effects
  • Change to drug interactions

Updated on 16-May-2008 and displayed until 15-Mar-2010

Reasons for adding or updating:

  • Transfer to upgraded management system

Updated on 01-Apr-2008 and displayed until 16-May-2008

Reasons for adding or updating:

  • Change to Marketing Authorisation Holder
  • Change to date of revision

Updated on 15-Sep-2006 and displayed until 01-Apr-2008

Reasons for adding or updating:

  • Change to, or new, use for medicine
  • Change to information about driving or using machinery
  • Change to how to administer the medicine
  • Change to side-effects
  • Change to date of revision

Updated on 10-Nov-2005 and displayed until 15-Sep-2006

Reasons for adding or updating:

  • Change to, or new, use for medicine

Updated on 11-May-2005 and displayed until 10-Nov-2005

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 18-Jan-2005 and displayed until 11-May-2005

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 17-Jan-2005 and displayed until 18-Jan-2005

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 13-Jan-2005 and displayed until 17-Jan-2005

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Norgine Limited

Company image
Address

Norgine House, Widewater Place, Moorhall Road, Harefield, Middlesex, UB9 6NS

Fax

+44 (0)1895 825 865

Medical Information e-mail
Telephone

+44 (0)1895 826 600

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

macrogol 3350, potassium chloride, sodium chloride, sodium hydrogen carbonate

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue